101 related articles for article (PubMed ID: 19160527)
1. A new type of tripropeptin with anteiso-branched chain fatty acid from Lysobacter sp. BMK333-48F3.
Hashizume H; Igarashi M; Sawa R; Adachi H; Nishimura Y; Akamatsu Y
J Antibiot (Tokyo); 2008 Sep; 61(9):577-82. PubMed ID: 19160527
[TBL] [Abstract][Full Text] [Related]
2. Tripropeptin E, a new tripropeptin group antibiotic produced by Lysobacter sp. BMK333-48F3.
Hashizume H; Hattori S; Igarashi M; Akamatsu Y
J Antibiot (Tokyo); 2004 Jun; 57(6):394-9. PubMed ID: 15323129
[No Abstract] [Full Text] [Related]
3. Genome Sequence of
Arlt P; Hashizume H; Igarashi M; Gross H
Microbiol Resour Announc; 2021 Dec; 10(49):e0096921. PubMed ID: 34881974
[No Abstract] [Full Text] [Related]
4. Corrigendum: A new type of tripropeptin with anteiso-branched chain fatty acid from Lysobacter sp. BMK333-48F3.
Hashizume H; Igarashi M; Sawa R; Adachi H; Nishimura Y; Akamatsu Y
J Antibiot (Tokyo); 2016 Dec; 69(12):892-893. PubMed ID: 27994235
[No Abstract] [Full Text] [Related]
5. Synthesis and antibacterial activity of tripropeptin C derivatives modified at the carboxyl groups.
Hirosawa S; Takahashi Y; Hashizume H; Miyake T; Akamatsu Y
J Antibiot (Tokyo); 2014 Mar; 67(3):265-8. PubMed ID: 24301184
[No Abstract] [Full Text] [Related]
6. Tripropeptins, novel antimicrobial agents produced by Lysobacter sp. I. Taxonomy, isolation and biological activities.
Hashizume H; Igarashi M; Hattori S; Hori M; Hamada M; Takeuchi T
J Antibiot (Tokyo); 2001 Dec; 54(12):1054-9. PubMed ID: 11858660
[TBL] [Abstract][Full Text] [Related]
7. A new anti-MRSA antibiotic complex, WAP-8294A II. Structure characterization of minor components by ESI LCMS and MS/MS.
Kato A; Hirata H; Ohashi Y; Fujii K; Mori K; Harada K
J Antibiot (Tokyo); 2011 May; 64(5):373-9. PubMed ID: 21326252
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of the anti-methicillin-resistant Staphylococcus aureus WAP-8294A2 biosynthetic gene cluster from Lysobacter enzymogenes OH11.
Zhang W; Li Y; Qian G; Wang Y; Chen H; Li YZ; Liu F; Shen Y; Du L
Antimicrob Agents Chemother; 2011 Dec; 55(12):5581-9. PubMed ID: 21930890
[TBL] [Abstract][Full Text] [Related]
9. Identification of an Anti-MRSA Cyclic Lipodepsipeptide, WBP-29479A1, by Genome Mining of
Sang M; Wang H; Shen Y; Rodrigues de Almeida N; Conda-Sheridan M; Li S; Li Y; Du L
Org Lett; 2019 Aug; 21(16):6432-6436. PubMed ID: 31386380
[No Abstract] [Full Text] [Related]
10. Tripropeptin C blocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate.
Hashizume H; Sawa R; Harada S; Igarashi M; Adachi H; Nishimura Y; Nomoto A
Antimicrob Agents Chemother; 2011 Aug; 55(8):3821-8. PubMed ID: 21628543
[TBL] [Abstract][Full Text] [Related]
11. Lysobactin, a novel antibacterial agent produced by Lysobacter sp. I. Taxonomy, isolation and partial characterization.
O'Sullivan J; McCullough JE; Tymiak AA; Kirsch DR; Trejo WH; Principe PA
J Antibiot (Tokyo); 1988 Dec; 41(12):1740-4. PubMed ID: 3209465
[TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial serratamolides and diacyl peptoglucosamine derivatives from Serratia sp.
Dwivedi D; Jansen R; Molinari G; Nimtz M; Johri BN; Wray V
J Nat Prod; 2008 Apr; 71(4):637-41. PubMed ID: 18303848
[TBL] [Abstract][Full Text] [Related]
13. Mumiamicin: Structure and bioactivity of a new furan fatty acid from Mumia sp. YSP-2-79.
Kimura T; Tajima A; Inahashi Y; Iwatsuki M; Kasai H; Mokudai T; Niwano Y; Shiomi K; Takahashi Y; Ōmura S; Nakashima T
J Gen Appl Microbiol; 2018 May; 64(2):62-67. PubMed ID: 29367492
[TBL] [Abstract][Full Text] [Related]
14. Miuraenamides A and B, novel antimicrobial cyclic depsipeptides from a new slightly halophilic myxobacterium: taxonomy, production, and biological properties.
Iizuka T; Fudou R; Jojima Y; Ogawa S; Yamanaka S; Inukai Y; Ojika M
J Antibiot (Tokyo); 2006 Jul; 59(7):385-91. PubMed ID: 17025014
[TBL] [Abstract][Full Text] [Related]
15. MBJ-0086 and MBJ-0087, new bicyclic depsipeptides, from Sphaerisporangium sp. 33226.
Kawahara T; Itoh M; Izumikawa M; Hashimoto J; Sakata N; Tsuchida T; Shin-ya K
J Antibiot (Tokyo); 2015 Jan; 68(1):67-70. PubMed ID: 25095808
[No Abstract] [Full Text] [Related]
16. Yield Improvement of the Anti-MRSA Antibiotics WAP-8294A by CRISPR/dCas9 Combined with Refactoring Self-Protection Genes in Lysobacter enzymogenes OH11.
Yu L; Su W; Fey PD; Liu F; Du L
ACS Synth Biol; 2018 Jan; 7(1):258-266. PubMed ID: 29125739
[TBL] [Abstract][Full Text] [Related]
17. Paleic acid, a fatty acid from Paenibacillus sp.: taxonomy, fermentation, isolation, structure determination, and anti-Mannheimia and -Pasteurella activity.
Kurata I; Umekita M; Sawa T; Hattori S; Hayashi C; Kinoshita N; Homma Y; Igarashi M; Hamada M; Watanabe T; Sawa R; Naganawa H; Takahashi Y; Akamatsu Y
J Antibiot (Tokyo); 2010 Aug; 63(8):519-23. PubMed ID: 20664607
[TBL] [Abstract][Full Text] [Related]
18. Isolation and structural characterisation of two antibacterial free fatty acids from the marine diatom, Phaeodactylum tricornutum.
Desbois AP; Lebl T; Yan L; Smith VJ
Appl Microbiol Biotechnol; 2008 Dec; 81(4):755-64. PubMed ID: 18813920
[TBL] [Abstract][Full Text] [Related]
19. Oleamycins A and B: new antibacterial cyclic hexadepsipeptides isolated from a terrestrial Streptomyces sp.
Raju R; Gromyko O; Andriy B; Fedorenko V; Luzhetskyy A; Müller R
J Antibiot (Tokyo); 2014 Apr; 67(4):339-43. PubMed ID: 24448627
[No Abstract] [Full Text] [Related]
20. Systematic optimization for production of the anti-MRSA antibiotics WAP-8294A in an engineered strain of Lysobacter enzymogenes.
Chen X; Li S; Yu L; Miller A; Du L
Microb Biotechnol; 2019 Nov; 12(6):1430-1440. PubMed ID: 31520522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
